October
24
Exagen’s AVISE® MTX Test Supports Horizon Therapeutics Clinical Trial to Evaluate Pegloticase with Methotrexate to Enhance Response Rates for People Living with Uncontrolled Gout
New study using Exagen’s test will enroll 135 subjects SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE)...